ICON plc (ICLR) Financial Analysis & Valuation | Quarter Chart
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support va... more
ICON Public Limited Company, a clinical research organization, provides outsourced development and c... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $14.29B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | IE | CEO | Barry Balfe |
| IPO Date | 1998-05-15 | CAGR | 21.59% |
| Employees | 40,200 | Website | www.iconplc.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.73% | Total Yield | 2.73% |
ICLR chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $17.53B | P/E | 15.11 | Forward P/E | 15.74 | PEG | -3.08 |
| P/S | 3.31 | P/B | 2.99 | P/CF | 17.39 | P/FCF | 20.86 |
| Sales | $8.25B | Sales 1Y | 2.01% | Sales 3Y | 4.42% | Sales 5Y | 158.6% |
| EPS | $12.26 | EPS 1Y | -56.17% | EPS 3Y | -30.95% | EPS 5Y | -37.53% |
| Sales QoQ | 1.45% | EPS QoQ | -30.88% | Sales QoQ Avg | 0.6% | EPS QoQ Avg | 1532.91% |
| Gross Margin | 21.85% | Operating Margin | 10.15% | Profit Margin | 3.99% | ROCE | 6.72% |
| ROA | 2% | ROE | 4% | Altman Z Score | 2.05 | Piotroski Score | 7 |
| Current Ratio | 0.95 | Quick Ratio | 0.95 | Cash Ratio | 0.24 | Op. CF Ratio | 0.07 |
| Debt/Equity | 0.37 | Debt/Assets | 0.21 | Lt Debt/Equity | 0.24 | Lt Debt/Cap. | 0.18 |
| Intrst Cov. | 4.48 | Inventory Turnover | — | Asset Turnover | 0.5 | Receivables Turnover | 3.05 |
| Enterprise Value | $17.53B | P/E Ratio | 15.11 |
| Forward P/E | 15.74 | PEG Ratio | -3.08 |
| P/S Ratio | 3.31 | P/B Ratio | 2.99 |
| P/CF Ratio | 17.39 | P/FCF Ratio | 20.86 |
| EPS | $12.26 | EPS Growth 1Y | -56.17% |
| EPS Growth 3Y | -30.95% | EPS Growth 5Y | -37.53% |
| Revenue Growth 1Y | 2.01% | Gross Margin | 21.85% |
| Operating Margin | 10.15% | Profit Margin | 3.99% |
| ROE | 4% | ROA | 2% |
| ROCE | 6.72% | Current Ratio | 0.95 |
| Quick Ratio | 0.95 | Cash Ratio | 0.24 |
| Debt/Equity | 0.37 | Interest Coverage | 4.48 |
| Altman Z Score | 2.05 | Piotroski Score | 7 |
ICON plc (ICLR) valuation & financials
ICON plc (ICLR) has a market capitalization of $14.29B and trades at a price-to-earnings ratio of 15.1. It operates in the Healthcare sector (Medical - Diagnostics & Research).
ICON plc's revenue grew +2.0% over the last year.
ICON plc's next earnings report is scheduled for October 27, 2026 after market close (provider scheduled date); analysts estimate EPS of $2.65. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)